Important: Before ordering this test, please read the above, “Important Information about Cyrex Antibody Testing”
Cyrex Array 14 is a very cost effective, easy, and non-invasive method, to measure mucosal immune reactivity to a range of exogenous and endogenous antigens. The categories of antigens include assessments for intestinal dysfunction, food immune reactivity, gut dysbiosis, infection and possible enteric nervous system autoimmune reactivity. This mucosal immune response is the body’s first immune system reaction. If steps to bring balance back to the mucosal immune response are not taken, the immune reactivity may result in a breach of the intestinal barrier, followed by a systemic immune reaction. The inflammation of systemic autoantibodies contributes to the progression of autoimmune and neuroautoimmune reactivities.
Cyrex Array 14 can be useful for clients who:
Have chronic inflammatory bowel condition
Have a family history of autoimmune disease
Cyrex Array 14 can be used to:
Evaluate mechanisms of compromised immune tolerance.
Evaluate possible outcomes of compromised mucosal tolerance, such as: intestinal barrier dysfunction, food and chemical immune reactivity, and autoimmunity.
Your test includes a 15 minute Interpretation of your results with Michelle Ross, Director of Clinical Services. Please Note: The test interpretation consultation must take place within 3 monthsof placing the test order.
Specimen: oral fluid
Price includes collection kit, and second Day UPS return shipping.
Orders for Cyrex Array 14 are accepted from the United States and Canada only. Cyrex tests are not available in New York State.
Cyrex Laboratories is not contracted with any insurance provider.
Cyrex Laboratories is CLIA* certified and licensed in the state of Arizona. Cyrex participates in CAP (College of American Pathologists) surveys to assure quality procedures and regulatory compliance. Cyrex Laboratories follows the strictest federal guidelines for the development of its assays.
*Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988, establishing quality standards for all laboratory testing to ensure the accuracy, reliability, and timeliness of patient test results regardless of where the test is performed.